Acorah Software Products - Accounts Production 16.1.300 true true 31 May 2023 1 June 2022 false true No description of principal activity 1 June 2023 31 May 2024 31 May 2024 12602078 Mr Ryan Clark Mr Daniel Horne iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12602078 2023-05-31 12602078 2024-05-31 12602078 2023-06-01 2024-05-31 12602078 frs-bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 12602078 frs-bus:FilletedAccounts 2023-06-01 2024-05-31 12602078 frs-bus:Micro-entities 2023-06-01 2024-05-31 12602078 frs-bus:EntityHasNeverTraded 2023-06-01 2024-05-31 12602078 frs-bus:AuditExempt-NoAccountantsReport 2023-06-01 2024-05-31 12602078 frs-bus:Director1 2023-06-01 2024-05-31 12602078 frs-bus:Director2 2023-06-01 2024-05-31 12602078 2022-05-31 12602078 2023-05-31 12602078 2022-06-01 2023-05-31
Registered number: 12602078
Frontline Medical Group Ltd
Unaudited Financial Statements
For The Year Ended 31 May 2024
Balance Sheet
Registered number: 12602078
2024 2023
£ £
Current assets 2 2
NET CURRENT ASSETS 2 2
TOTAL ASSETS LESS CURRENT LIABILITIES 2 2
NET ASSETS 2 2
CAPITAL AND RESERVES 2 2

Notes

1. General Information
Frontline Medical Group Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 12602078 . The registered office is Suite 1a, Hunter House, 150 Hutton Road, Shenfield, Brentwood, CM15 8NL.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2023: NIL)
- -
For the year ending 31 May 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Ryan Clark
Director
10th December 2024